Join
Live feed
·
NEWSReleasevia Quantisnow
Onconova Therapeutics Inc. logo

Onconova Therapeutics shares are trading lower after the company announced that it entered into a definitive merger agreement to acquire 100% of Trawsfynydd's outstanding equity interests.

ByQuantisnow·Wall Street's wire, on your screen.
ONTX· Onconova Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ONTX (Onconova Therapeutics Inc.) and more on Quantisnow.